Quantitative electromyographic train-of-four monitoring to determine rocuronium infusion requirements during major surgery in pediatric patients.
- 1Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, United States.
- 2Department of Anesthesiology and Pain Medicine, The Ohio State University College of Medicine, Columbus, Ohio, United States.
Abstract
Background
Neuromuscular blocking agents (NMBAs) are commonly used during anesthetic care to facilitate endotracheal intubation, prevent intraoperative movement, and provide muscle relaxation during surgical procedures. Options for dosing include both intermittent bolus administration and continuous infusion.Methods
This prospective study investigated rocuronium infusion requirements during intraoperative care in a cohort of pediatric patients, using an electromyography (EMG)-based train-of-four monitor. Neuromuscular block (NMB) was provided by an initial intravenous bolus of rocuronium (0.5-0.6 mg/kg), followed by a continuous rocuronium infusion at 0.6 mg/kg/h, and titrated to maintain a train-of-four count (TOFC) of 1/4.Results
The final study cohort included 48 pediatric patients, ranging in age from 3 months to 18 years (median age 13 years) and in weight from 5.2 to 132 kg (median weight 55.9 kg). The total rocuronium infusion time across all patients was 11,735 min. The median initial bolus dose of rocuronium was 0.8 mg/kg (interquartile range [IQR]: 0.7, 1.1 mg/kg). The infusion dose ranged from 0.1 to 0.72 mg/kg/h (median dose 0.48 mg/kg/h). Twenty-six patients (54%) received at least one rescue bolus to maintain one twitch in the TOFC. Among these patients, the majority (n = 15, 58%) received only one rescue bolus during the procedure. The median rescue bolus dose administered was 0.2 mg/kg (IQR: 0.2, 0.3). There were no cases of residual NMB, no need for additional rescue reversal after the initial dose of sugammadex, or other adverse effects related to anesthetic care.Conclusion
Rocuronium infusion requirements can be accurately titrated using an EMG-based TOF monitor during prolonged surgical procedures. This study accurately provides a dosing scheme for the intraoperative use of rocuronium infusions during these procedures, demonstrating that the median infusion requirement is 0.48 mg/kg/h.
Related
- Quantitative Neuromuscular Monitoring in General Anesthesia: A Systematic Review of Recovery and Safety Outcomes
- Phase-specific neuromechanical signatures of 40-m sprint performance: an integrated two-dimensional kinematic and surface electromyographic profiling study
- Thyroid-cartilage and anterior-laryngeal electrodes provide higher and more frequently adequate electromyographic signals in intraoperative neuromonitoring during thyroid surgery: a systematic review and meta-analysis
- Preliminary laboratory analytical comparison of quantitative at-home urinary hormone monitoring systems using artificial urine
- Alpha-Mannosidosis: Quantitative Oligosaccharide Biomarker Analysis in Dried Blood Spots for Diagnosis, Newborn Screening, and Treatment Monitoring
BibTeX
@article{padilla2026quantitative,
title = {{Quantitative electromyographic train-of-four monitoring to determine rocuronium infusion requirements during major surgery in pediatric patients.}},
author = {Stephania Paredes Padilla and Edison E Villalobos and Ifeoluwa C Olakunle and Sibelle Aurelie Yemele Kitio and Julie Rice-Weimer and Joseph D Tobias},
journal = {Saudi journal of anaesthesia},
year = {2026},
month = oct,
doi = {10.4103/sja.sja_399_26},
url = {https://europepmc.org/article/MED/42960329},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Quantitative electromyographic train-of-four monitoring to determine rocuronium infusion requirements during major surgery in pediatric patients.
AU - Stephania Paredes Padilla
AU - Edison E Villalobos
AU - Ifeoluwa C Olakunle
AU - Sibelle Aurelie Yemele Kitio
AU - Julie Rice-Weimer
AU - Joseph D Tobias
PY - 2026
DA - 2026/10/01
JO - Saudi journal of anaesthesia
DO - 10.4103/sja.sja_399_26
UR - https://europepmc.org/article/MED/42960329
AB - Background Neuromuscular blocking agents (NMBAs) are commonly used during anesthetic care to facilitate endotracheal intubation, prevent intraoperative movement, and provide muscle relaxation during surgical procedures. Options for dosing include both intermittent bolus administration and continuous infusion.Methods This prospective study investigated rocuronium infusion requirements during intraoperative care in a cohort of pediatric patients, using an electromyography (EMG)-based train-of-four monitor. Neuromuscular block (NMB) was provided by an initial intravenous bolus of rocuronium (0.5-0.6 mg/kg), followed by a continuous rocuronium infusion at 0.6 mg/kg/h, and titrated to maintain a train-of-four count (TOFC) of 1/4.Results The final study cohort included 48 pediatric patients, ranging in age from 3 months to 18 years (median age 13 years) and in weight from 5.2 to 132 kg (median weight 55.9 kg). The total rocuronium infusion time across all patients was 11,735 min. The median initial bolus dose of rocuronium was 0.8 mg/kg (interquartile range [IQR]: 0.7, 1.1 mg/kg). The infusion dose ranged from 0.1 to 0.72 mg/kg/h (median dose 0.48 mg/kg/h). Twenty-six patients (54%) received at least one rescue bolus to maintain one twitch in the TOFC. Among these patients, the majority (n = 15, 58%) received only one rescue bolus during the procedure. The median rescue bolus dose administered was 0.2 mg/kg (IQR: 0.2, 0.3). There were no cases of residual NMB, no need for additional rescue reversal after the initial dose of sugammadex, or other adverse effects related to anesthetic care.Conclusion Rocuronium infusion requirements can be accurately titrated using an EMG-based TOF monitor during prolonged surgical procedures. This study accurately provides a dosing scheme for the intraoperative use of rocuronium infusions during these procedures, demonstrating that the median infusion requirement is 0.48 mg/kg/h.
SN - 1658-354X
SN - 0975-3125
ER -